Delivery Order SPE2DB24D2217-SPE2DB24FJVRV

Award Date 8/29/24
Potential Completion Date 8/30/24
Potential Value $2.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $8,083.44 firm fixed-price delivery order is for the pharmaceutical product "YUPELRI 175 MCG/3 ML SOLUTION UD 3ML". The contract has an ultimate completion date of April 24, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2025. This...
This federal contract award is for the delivery of the pharmaceutical product YUPELRI 175 MCG/3 ML SOLUTION UD 3ML to the Defense Logistics Agency (DLA), a defense agency. The $4,524.45 firm-fixed-price contract has a period of performance through June 5, 2025 and was awarded on June 4, 2025. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. This contract is not set aside and represents open competition....
This is a delivery order awarded under an Indefinite Delivery Contract (IDC) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $3,213.11 firm fixed-price contract is to provide the drug YUPELRI 175 MCG/3 ML SOLUTION UD 3ML to the Defense Logistics Agency (DLA). The contract has an ultimate completion date of March 19, 2024. AmerisourceBergen holds a $999,999,999 IDC with the DLA Troop Support Medical, which serves as the primary vehicle for providing a comprehensive range...
This is a $3,048.54 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of YUPELRI 175 MCG/3 ML SOLUTION UD 3ML, a medical product, with a completion date of June 26, 2025. The contract has no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of YUPELRI 175 MCG/3 ML SOLUTION UD 3ML, a pharmaceutical product, with a ceiling value of $3,330.74 and an ultimate completion date of May 22, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,208.56 firm fixed-price delivery order (Contract # SPE2DB22D1202 and SPE2DB24FVFH8) is for the supply of PYLERA CAPSULE UU 120S medical products. The contract has an ultimate completion date of July 1, 2024 and was awarded on June 28, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
The federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The $7,231.82 firm fixed-price delivery order has an ultimate completion date of April 25, 2024. The contract does not have a set-aside designation. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31,...
The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor, for the supply of various pharmaceutical products and medical supplies. The $1,855.80 Firm Fixed Price contract has an ultimate completion date of July 24, 2024 and is not designated as a set-aside. This Delivery Order is likely part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,558.62 firm fixed-price delivery order is for the supply of various pharmaceutical products and medical supplies to support federal healthcare programs. The contract has an ultimate completion date of July 30, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds several Indefinite Delivery Contracts (IDCs) with DLA and...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $297,547.36 firm-fixed-price delivery order is for the supply of pharmaceutical products and medical supplies, such as specialty medications, brand-name and generic drugs, vaccines, and medical equipment. The contract has an ultimate completion date of September 9, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been...
  • SPE2DB24D2217
    Indefinite Delivery Contract
  • SPE2DB24D2217-SPE2DB24FJVRV
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The $2,285.23 firm-fixed-price delivery order is for the supply of YUPELRI 175 MCG/3 ML SOLUTION UD 3ML, a pharmaceutical product. The contract has an ultimate completion date of August 30, 2024 and does not utilize any set-aside designations.

Amerisourcebergen, a major pharmaceutical distributor, has been awarded numerous federal contracts and Indefinite Delivery Contracts (IDCs) by various defense and civilian agencies to supply a diverse range of medical commodities, including prescription drugs, vaccines, and medical supplies. The company's significant IDC with the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, is a key vehicle for delivering these essential products to military treatment facilities and programs worldwide.

Generated 11/28/24, 9:06 AM